You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤 | 泰格醫藥(3347.HK)暗盤段大漲15%
格隆匯 08-06 16:27
格隆匯8月6日丨據輝立證券,泰格醫藥(3347.HK)暗盤段現報115.2港元,較發行價100港元漲15.2%。公司是中國領先的綜合生物製藥研發服務提供商,2017年至2019年收益分別為16.82億、22.99億、28.03億元人民幣,溢利分別為3.94億、6.55億、9.74億元人民幣,每股有形資產淨值14.56-16.01港元。此次全球發售約1.07億股H股,其中香港發售2301.9萬股H股,國際發售8404.61萬股H股,每手100股,淨籌102.725億港元,香港公開發售獲414.39倍認購。國盛證券指,公司是國內臨牀CRO龍頭,國內政策紅利下增長強勁,深化全球佈局提高成長天花板,H股上市後成長有望再提速,堅定看好公司發展。首次覆蓋,給予“買入”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account